- Home
- YMAB vs IIIN Comparison
YMAB vs IIIN Comparison
Compare YMAB & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- IIIN
- Stock Information
- Founded
- YMAB 2015
- IIIN 1953
- Country
- YMAB United States
- IIIN United States
- Employees
- YMAB N/A
- IIIN N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- IIIN Steel/Iron Ore
- Sector
- YMAB Health Care
- IIIN Industrials
- Exchange
- YMAB Nasdaq
- IIIN Nasdaq
- Market Cap
- YMAB 631.1M
- IIIN 587.8M
- IPO Year
- YMAB 2018
- IIIN N/A
- Fundamental
- Price
- YMAB $11.14
- IIIN $30.14
- Analyst Decision
- YMAB Strong Buy
- IIIN
- Analyst Count
- YMAB 8
- IIIN 0
- Target Price
- YMAB $21.38
- IIIN N/A
- AVG Volume (30 Days)
- YMAB 268.9K
- IIIN 124.0K
- Earning Date
- YMAB 11-08-2024
- IIIN 10-17-2024
- Dividend Yield
- YMAB N/A
- IIIN 0.40%
- EPS Growth
- YMAB N/A
- IIIN N/A
- EPS
- YMAB N/A
- IIIN 0.99
- Revenue
- YMAB $84,553,000.00
- IIIN $529,198,000.00
- Revenue This Year
- YMAB $10.24
- IIIN $9.60
- Revenue Next Year
- YMAB $20.21
- IIIN $16.98
- P/E Ratio
- YMAB N/A
- IIIN $30.44
- Revenue Growth
- YMAB N/A
- IIIN N/A
- 52 Week Low
- YMAB $5.17
- IIIN $26.74
- 52 Week High
- YMAB $20.90
- IIIN $39.38
- Technical
- Relative Strength Index (RSI)
- YMAB 25.01
- IIIN 57.20
- Support Level
- YMAB $12.47
- IIIN $29.82
- Resistance Level
- YMAB $15.69
- IIIN $30.50
- Average True Range (ATR)
- YMAB 0.97
- IIIN 0.66
- MACD
- YMAB -0.46
- IIIN 0.35
- Stochastic Oscillator
- YMAB 9.88
- IIIN 85.71
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.